(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.71%.
Coya Therapeutics's earnings in 2026 is -$21,126,340.On average, 8 Wall Street analysts forecast COYA's earnings for 2026 to be -$31,296,574, with the lowest COYA earnings forecast at -$34,941,820, and the highest COYA earnings forecast at -$26,846,746. On average, 6 Wall Street analysts forecast COYA's earnings for 2027 to be -$27,097,738, with the lowest COYA earnings forecast at -$38,160,145, and the highest COYA earnings forecast at -$15,763,227.
In 2028, COYA is forecast to generate -$26,318,959 in earnings, with the lowest earnings forecast at -$47,815,122 and the highest earnings forecast at -$2,955,605.